Podcasts about leemore dafny

Subscribe to UnitedHealthcare's Community & State newsletter.Health Affairs' Jeff Byers is joined by Jason Resendez, President and CEO of the National Alliance for Caregiving, to discuss the recent finalization of CMS's 2025 Medicare Physician Fee Schedule and how these policies will impact family caregivers and the integration of these individuals into the health care system.  Health Affairs's Research and Justice For All podcast returns for its second season, focusing on drivers of health. Check out the first episode.  Check out the 200th episode of A Health Podyssey featuring Leemore Dafny of the Harvard Business School discussing vertical integration.  Join Health Affairs on November 20 for a virtual event with John Bowblis examining how the loss of public health emergency funds challenges the financial viability of nursing homes.Related Articles:PRESS RELEASE: HHS Finalizes Physician Payment Rule Strengthening Person-Centered Care and Health Quality Measures 11/20/2024: Caregiver Nation Summit (Agenda and Virtual Attendance Options) Subscribe to UnitedHealthcare's Community & State newsletter.

Subscribe to UnitedHealthcare's Community & State newsletter.Welcome to the 200th episode of A Health Podyssey!For our 200th episode, Health Affairs' Editor-in-Chief Alan Weil invites Leemore Dafny of the Harvard Business School back to the program to discuss vertical integration in the health care sector, observations on what impacts it may have on the future state of markets, and what the regulatory response has been so far.Dafny joined us for our 100th episode discussing her research published in Health Affairs that examined donations made by pharmaceutical manufacturers to patient assistance charities based on an analysis of drug spending among Medicare Advantage enrollees.   Thank you for supporting and listening to A Health Podyssey.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone. Subscribe to UnitedHealthcare's Community & State newsletter.

On our 100th episode, Leemore Dafny from Harvard Business School joins Health Affairs Editor-in-Chief Alan Weil to discuss her recent research published in Health Affairs examining donations made by pharmaceutical manufacturers to patient assistance charities based on an analysis of drug spending among Medicare Advantage enrollees. Order the September 2022 issue of Health Affairs for research on nurses, care delivery, pharmaceuticals, and more.Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.Read the Full Episode Transcript here.Subscribe: RSS | Apple Podcasts | Spotify | Stitcher | Google Podcasts

Dr. Leemore Dafny is a professor of business administration at Harvard Business School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. L.S. Dafny. A Radical Treatment for Insulin Pricing. N Engl J Med 2022;386:2157-2159.

The US government reports that the total spending on hospital care in 2019 was almost $1.2 trillion. High and highly variable hospital prices have been in the news recently in part due to new information made available under the price transparency rules implemented by the Trump administration.Competitive markets are supposed to constrain prices, but in much of the US, there's little competition among hospitals and consolidation throughout the healthcare sector has contributed to that consolidation. The result is a number of proposals to regulate health care prices in general and for hospital prices in particular. Leemore Dafny from the Harvard Business School and Harvard Kennedy School joins Health Affairs Editor-in-Chief Alan Weil to discuss her latest research on hospital prices and market concentration. Dafny and colleagues published a paper in the September 2021 issue of Health Affairs analyzing hospital prices and relating them to market concentration. The authors found the relationship isn't as straightforward as one might expect — but the findings still have major implications for any consideration of regulating hospital prices. If you like this interview, order the September issue of Health Affairs.Pre-order the October Perinatal Mental Health Theme Issue.Subscribe: RSS | Apple Podcasts | Spotify | Stitcher | Google Podcasts

Americans pay more money – sometimes much more money – for prescriptions than consumers in many other wealthy countries. Why? The drivers are many and complicated. Pharmaceutical companies, employers, health care providers, patients, lawmakers, and pharmacy benefit managers all play a role. Calls to make prescriptions more affordable have prompted new efforts, including at the federal level. Last May, for example, President Trump introduced a plan intended to help reduce drug prices. This Forum event aimed to demystify the prescription drug pricing process. Experts weighed issues such as regulation, price negotiation and competitive market pressures, ultimately asking why prescription costs matter for public health. Part of The Dr. Lawrence H. and Roberta Cohn Forums, this event was presented jointly with Reuters on September 26, 2018.

Dr. Leemore Dafny is a professor of business administration at Harvard Business School and a faculty research fellow at the National Bureau of Economic Research. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. L.S. Dafny. Does CVS–Aetna Spell the End of Business as Usual? N Engl J Med 2018;378:593-5.

Suzanne dials up Leemore Dafny, a Harvard professor and economist, to find out how she keeps a “glass half full” outlook in the face of provider consolidation and higher prices in health care. She draws on her economics expertise to share specific ideas on what employers and others can do to increase competition.

Dr. Leemore Dafny is a professor of business administration at Harvard Business School and a faculty research fellow at the National Bureau of Economic Research. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. L.S. Dafny, C.J. Ody, and M.A. Schmitt. Undermining Value-Based Purchasing - Lessons from the Pharmaceutical Industry. N Engl J Med 2016;375:2013-5.

Leemore Dafny is a professor of management and strategy at the Kellogg School of Management at Northwestern University. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. L.S. Dafny and T.H. Lee. The Good Merger. N Engl J Med 2015;372:2077-9.